Literature DB >> 16009496

Regulation of neuronal death and calcitonin gene-related peptide by fibroblast growth factor-2 and FGFR3 after peripheral nerve injury: evidence from mouse mutants.

J Jungnickel1, A Klutzny, S Guhr, K Meyer, C Grothe.   

Abstract

The presence and regulation of basic fibroblast growth factor and its high-affinity tyrosine kinase receptor FGFR3 in sensory neurons during development and after peripheral nerve injury suggest a physiological role of the fibroblast growth factor-2 system for survival and maintenance of sensory neurons. Here we investigated L5 spinal ganglia of intact and lesioned fibroblast growth factor-2 knock-out and FGFR3 knock-out mice. Quantification of sensory neurons in intact L5 spinal ganglia revealed no differences between wild-types and mutant mice. After sciatic nerve axotomy, the normally occurring neuron loss in wild-type mice was significantly reduced in both knock-out strains suggesting that fibroblast growth factor-2 is involved in neuronal death mediated via FGFR3. In addition, the number of chromatolytic and eccentric cells was significantly increased in fibroblast growth factor-2 knock-out mice indicating a transient protection of injured spinal ganglia neurons in the absence of fibroblast growth factor-2. The expression of the neuropeptide calcitonin gene-related peptide in sensory neurons of intact fibroblast growth factor-2 knock-out and FGFR3 knock-out mice was not changed in comparison to adequate wild-types. Fibroblast growth factor-2 wild-type and FGFR3 wild-type mice showed a lesion-induced decrease of calcitonin gene-related peptide-positive neurons in ipsilateral L5 spinal ganglia whereas the loss of calcitonin gene-related peptide-immunoreactive sensory neurons is reduced in the absence of fibroblast growth factor-2 or FGFR3, respectively. In addition, FGFR3 wild-type and knock-out mice displayed a contralateral reduction of the neuropeptide after axotomy. These results suggest that endogenous fibroblast growth factor-2 and FGFR3 are crucially involved in the regulation of survival and calcitonin gene-related peptide expression of lumbar sensory neurons after lesion, but not during development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16009496     DOI: 10.1016/j.neuroscience.2005.04.066

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  5 in total

1.  Fibroblast growth factor (FGF)-2 and FGF receptor 3 are required for the development of the substantia nigra, and FGF-2 plays a crucial role for the rescue of dopaminergic neurons after 6-hydroxydopamine lesion.

Authors:  Marco Timmer; Konstantin Cesnulevicius; Christian Winkler; Julia Kolb; Esther Lipokatic-Takacs; Julia Jungnickel; Claudia Grothe
Journal:  J Neurosci       Date:  2007-01-17       Impact factor: 6.167

2.  Analysis of the fibroblast growth factor system reveals alterations in a mouse model of spinal muscular atrophy.

Authors:  Niko Hensel; Andreas Ratzka; Hella Brinkmann; Lars Klimaschewski; Claudia Grothe; Peter Claus
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240

3.  Electro-acupuncture promotes the proliferation of neural stem cells and the survival of neurons by downregulating miR-449a in rat with spinal cord injury.

Authors:  Yi Zhu; Yaochi Wu; Rong Zhang
Journal:  EXCLI J       Date:  2017-03-23       Impact factor: 4.068

4.  bFGF promotes neurological recovery from neonatal hypoxic-ischemic encephalopathy by IL-1β signaling pathway-mediated axon regeneration.

Authors:  Zheng Ma; Fang Wang; Lu-Lu Xue; Ying-Jie Niu; Yue Hu; Zhang-Yu Su; Jin Huang; Rui-Ze Niu; Ting-Hua Wang; Ying-Chun Ba; Liu-Lin Xiong; Xue Bai
Journal:  Brain Behav       Date:  2020-06-11       Impact factor: 2.708

5.  Bone marrow-derived fibroblast growth factor-2 induces glial cell proliferation in the regenerating peripheral nervous system.

Authors:  Victor Tulio Ribeiro-Resende; Alvaro Carrier-Ruiz; Robertha M R Lemes; Ricardo A M Reis; Rosalia Mendez-Otero
Journal:  Mol Neurodegener       Date:  2012-07-13       Impact factor: 14.195

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.